Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nutt

Showing results (51-60 of 179) with videos related to

Pageof 18
Sort By:
Ebiomedicine|December 3, 2015
A Lifetime Prevalence of Comorbidity Between Bipolar Affective Disorder and Anxiety Disorders: A Meta-analysis of 52 Interview-based Studies of Psychiatric PopulationBehrouz Nabavi, Alex J Mitchell, David Nutt
British Journal of Clinical Pharmacology|July 17, 2023
Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael RawlinsBalázs Szigeti, Lawrence D Phillips, David Nutt
Reviews in the Neurosciences|June 17, 2005
Human functional neuroimaging connectivity research in dependenceMark Daglish, Anne Lingford-Hughes, David Nutt
Current Topics in Behavioral Neurosciences|May 26, 2018
Imaging and Genetic Approaches to Inform Biomarkers for Anxiety Disorders, Obsessive-Compulsive Disorders, and PSTDEduard Maron, Chen-Chia Lan, David Nutt
The British Journal of Psychiatry : the Journal of Mental Science|May 19, 2024
Is it now time to prepare psychiatry for a psychedelic future?David Nutt, Ilana Crome, Allan H Young
Cell|April 4, 2020
Psychedelic Psychiatry's Brave New WorldDavid Nutt, David Erritzoe, Robin Carhart-Harris
Current Topics in Behavioral Neurosciences|November 30, 2018
Correction to: Imaging and Genetic Approaches to Inform Biomarkers for Anxiety Disorders, Obsessive-Compulsive Disorders, and PSTDEduard Maron, Chen-Chia Lan, David Nutt
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 2, 2006
Generalized anxiety disorder: A comorbid diseaseDavid Nutt, Spilos Argyropoulos, Sean Hood, et al.
BMJ Case Reports|July 17, 2019
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participantsBen Sessa, Chloe Sakal, Steve O'Brien, et al.
Psychopharmacology|February 16, 2018
Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulationH Valerie Curran, David Nutt, Harriet de Wit
Pageof 18

Showing results (51-60 of 179) with videos related to

Sort By:
Pageof 18
Ebiomedicine|December 3, 2015
A Lifetime Prevalence of Comorbidity Between Bipolar Affective Disorder and Anxiety Disorders: A Meta-analysis of 52 Interview-based Studies of Psychiatric PopulationBehrouz Nabavi, Alex J Mitchell, David Nutt
British Journal of Clinical Pharmacology|July 17, 2023
Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael RawlinsBalázs Szigeti, Lawrence D Phillips, David Nutt
Reviews in the Neurosciences|June 17, 2005
Human functional neuroimaging connectivity research in dependenceMark Daglish, Anne Lingford-Hughes, David Nutt
Current Topics in Behavioral Neurosciences|May 26, 2018
Imaging and Genetic Approaches to Inform Biomarkers for Anxiety Disorders, Obsessive-Compulsive Disorders, and PSTDEduard Maron, Chen-Chia Lan, David Nutt
The British Journal of Psychiatry : the Journal of Mental Science|May 19, 2024
Is it now time to prepare psychiatry for a psychedelic future?David Nutt, Ilana Crome, Allan H Young
Cell|April 4, 2020
Psychedelic Psychiatry's Brave New WorldDavid Nutt, David Erritzoe, Robin Carhart-Harris
Current Topics in Behavioral Neurosciences|November 30, 2018
Correction to: Imaging and Genetic Approaches to Inform Biomarkers for Anxiety Disorders, Obsessive-Compulsive Disorders, and PSTDEduard Maron, Chen-Chia Lan, David Nutt
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 2, 2006
Generalized anxiety disorder: A comorbid diseaseDavid Nutt, Spilos Argyropoulos, Sean Hood, et al.
BMJ Case Reports|July 17, 2019
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participantsBen Sessa, Chloe Sakal, Steve O'Brien, et al.
Psychopharmacology|February 16, 2018
Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulationH Valerie Curran, David Nutt, Harriet de Wit
Pageof 18